Oversight of clinical gene therapy studies in Australia

被引：0

|

作者：

Trent, RJA ^{[1
]}

机构：

[1] Natl Hlth & Med Res Council, GTRAP, Canberra, ACT 2615, Australia

来源：

JOURNAL OF GENE MEDICINE | 2005年 / 7卷 / 08期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：1116 / 1117

页数：2

相关论文

共 50 条

[1] Oversight and monitoring of clinical research with gene therapy in Australia
Trent, RJA
MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (09) : 441 - 442
[2] Is it time to reform oversight of clinical gene therapy in the EU?
Kenter, Marcel J. H.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (01) : 8 - 10
[3] Gene therapy trials oversight
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (15): : 1950 - 1950
[4] Gene Therapy Oversight: Lessons for Nanobiotechnology
Wolf, Susan M.
Gupta, Rishi
Kohlhepp, Peter
JOURNAL OF LAW MEDICINE & ETHICS, 2009, 37 (04): : 659 - 684
[5] The oversight of gene therapy research.
Spink, J
CANCER GENE THERAPY, 1999, 6 (04) : 389 - 389
[6] RAC to finally relax gene therapy oversight
Mullard, Asher
NATURE BIOTECHNOLOGY, 2014, 32 (09) : 858 - 858
[7] RAC to finally relax gene therapy oversight
Asher Mullard
Nature Biotechnology, 2014, 32 : 858 - 858
[8] HIV vector challenges gene therapy oversight
Fox, JL
NATURE BIOTECHNOLOGY, 1997, 15 (09) : 832 - 832
[9] HIV vector challenges gene therapy oversight
Jeffrey L Fox
Nature Biotechnology, 1997, 15 : 832 - 832
[10] HIV vector challenges gene therapy oversight
Nat Biotechnol, 9 (832):

← 1 2 3 4 5 →